Zobrazeno 1 - 10
of 16
pro vyhledávání: '"J A, Moscow"'
Autor:
K H, Cowan, J A, Moscow, H, Huang, J A, Zujewski, J, O'Shaughnessy, B, Sorrentino, K, Hines, C, Carter, E, Schneider, G, Cusack, M, Noone, C, Dunbar, S, Steinberg, W, Wilson, B, Goldspiel, E J, Read, S F, Leitman, K, McDonagh, C, Chow, A, Abati, Y, Chiang, Y N, Chang, M M, Gottesman, I, Pastan, A, Nienhuis
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(7)
The MDR1 multidrug resistance gene confers resistance to natural-product anticancer drugs including paclitaxel. We conducted a clinical gene therapy study to determine whether retroviral-mediated transfer of MDR1 in human hematopoietic cells would re
Autor:
J A, Moscow, H, Huang, C, Carter, K, Hines, J, Zujewski, G, Cusack, C, Chow, D, Venzon, B, Sorrentino, Y, Chiang, B, Goldspiel, S, Leitman, E J, Read, A, Abati, M M, Gottesman, I, Pastan, S, Sellers, C, Dunbar, K H, Cowan
Publikováno v:
Blood. 94(1)
To determine whether the multidrug resistance gene MDR1 could act as a selectable marker in human subjects, we studied engraftment of peripheral blood progenitor cells (PBPCs) transduced with either MDR1 or the bacterial NeoR gene in six breast cance
Publikováno v:
International journal of cancer. 72(1)
Methotrexate transport deficiency due to decreased reduced folate carrier (RFC) activity has been observed in several cell lines selected for resistance to methotrexate (MTX). Since MTX resistance is multifactorial, however, it is difficult to quanti
Publikováno v:
Blood. 89(7)
Ohnuma et al reported a series of methotrexate-resistant MOLT-3 human T-cell acute lymphoblastic leukemia cell lines that showed decreasing methotrexate (MTX) uptake as the sublines acquired increasing MTX resistance (Cancer Res 45:1815, 1985). The a
Publikováno v:
Cancer chemotherapy and biological response modifiers. 17
Publikováno v:
Cancer research. 55(17)
Our laboratory has previously reported the isolation of a murine cDNA which restores reduced folate carrier (RFC) activity and methotrexate (MTX) sensitivity to a MTX-resistant, transport-deficient human breast cancer cell line (MTXR ZR-75-1) (K. H.
Publikováno v:
Cancer chemotherapy and biological response modifiers. 15
Autor:
J A, Moscow, R, He, J R, Gnarra, T, Knutsen, Y, Weng, W P, Zhao, J, Whang-Peng, W M, Linehan, K H, Cowan
Publikováno v:
Oncogene. 9(1)
rhoA encodes a ras-related GTP-binding protein that is thought to play a role in cytoskeletal organization. Recent evidence has suggested both that rhoA could act either as a dominant oncogene, since transfection of both normal and activated rho gene
Publikováno v:
The Journal of biological chemistry. 267(9)
Human selenium-dependent glutathione peroxidase (hGPx1) (EC 1.11.1.9) is thought to be involved in many critical cellular functions as a result of its role in glutathione-mediated reduction of toxic peroxides, and it is implicated as a mechanism of r
Autor:
J A, Moscow, K H, Cowan
Publikováno v:
Cancer chemotherapy and biological response modifiers. 12
The ability of malignant cells to develop resistance to cytotoxic drugs poses a major obstacle to the ultimate success of cancer therapy. While some mechanisms of resistance allow cells to survive exposure to a single agent, the phenomenon of multidr